Related Experiment Video
Updated: Aug 10, 2026
Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
The prognosis of polyostotic eosinophilic granuloma
1Department of Pathology, Pahlavi University, Shiraz, Iran.
Insights
Polyostotic histiocytosis without visceral involvement rarely progresses to systemic disease. Long-term follow-up shows most patients remain healthy, with radiation therapy potentially aiding lesion healing.
Area of Science:
- Histiocytosis
- Pediatric Endocrinology
- Orthopedic Oncology
Background:
- Polyostotic histiocytosis is a rare disorder characterized by bone lesions.
- Understanding its natural history and treatment is crucial for patient outcomes.
Observation:
- Nine cases of polyostotic histiocytosis without visceral involvement were studied with long-term follow-up.
- Only one patient presented with the full Hand-Schüller-Christian triad (osteolytic lesions, diabetes insipidus, exophthalmos).
- Lesions evolved over time in some patients, with initial solitary lesions becoming multiple within a decade.
Findings:
- No cases progressed to systemic histiocytosis.
- Eight out of nine patients were in good health 7-18 years post-diagnosis.
- Low-dose radiation therapy appeared to accelerate lesion healing.
Implications:
- Polyostotic histiocytosis without visceral involvement generally has a favorable long-term prognosis.
- Early diagnosis and management, potentially including radiation therapy, can improve outcomes.
- This study highlights the importance of long-term monitoring for patients with histiocytosis.
Abstract:
Nine examples of polyostotic histiocytosis without visceral involvement with long-term follow-up are presented. Only one patient had the complete Hand-Schüller-Christian disease triad of multiple osteolytic lesions, diabetes insipidus, and exophthalmos. Three of the nine patients had solitary osseous lesions when first seen but other lesions developed within ten years. The other six had multiple lesions when first seen. In no case was progression to systemic histiocytosis observed. Eight patients were well and in good health seven to 18 years after initial diagnosis. One died indirectly of his disease. Low-dose radiation therapy seems to accelerate healing of lesions.
